Cargando…

Inflammatory myofibroblastic tumours: a pictorial review

OBJECTIVES: To present the most important characteristics of inflammatory myofibroblastic tumours (IMTs) arising in different locations of the body with histological correlation. METHODS: To review the symptoms and main radiological findings of IMTs. On ultrasonography (US), these tumours can appear...

Descripción completa

Detalles Bibliográficos
Autores principales: Cantera, Jon Etxano, Alfaro, María Páramo, Rafart, David Cano, Zalazar, Romina, Muruzabal, Maite Millor, Barquín, Paula García, Pérez, Isabel Vivas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4330239/
https://www.ncbi.nlm.nih.gov/pubmed/25519466
http://dx.doi.org/10.1007/s13244-014-0370-0
_version_ 1782357557306720256
author Cantera, Jon Etxano
Alfaro, María Páramo
Rafart, David Cano
Zalazar, Romina
Muruzabal, Maite Millor
Barquín, Paula García
Pérez, Isabel Vivas
author_facet Cantera, Jon Etxano
Alfaro, María Páramo
Rafart, David Cano
Zalazar, Romina
Muruzabal, Maite Millor
Barquín, Paula García
Pérez, Isabel Vivas
author_sort Cantera, Jon Etxano
collection PubMed
description OBJECTIVES: To present the most important characteristics of inflammatory myofibroblastic tumours (IMTs) arising in different locations of the body with histological correlation. METHODS: To review the symptoms and main radiological findings of IMTs. On ultrasonography (US), these tumours can appear as hypoechoic or hyperechoic masses and a variable Doppler appearance with increased vascularity. Computed tomography (CT) and magnetic resonance (MR) are the most used imaging tools in their evaluation. On contrast-enhanced CT, IMTs can appear as homogeneous or heterogeneous lesions, with variable enhancement on delayed acquisitions due to fibrosis. These findings are also present on gadolinium contrast-enhanced MR. On T1-weighted and T2-weighted sequences, IMTs usually show low signal intensity reflecting also the presence of fibrotic tissue. RESULTS: To show the main clinical symptoms and radiological features of IMTs in different locations: head and neck, lung, genitourinary, hepatic, splenic, gastrointestinal tract, mesenteric, muskuloskeletal. CONCLUSIONS: Although IMTs in some organs are not uncommon, they are not usually included in the differential diagnosis of masses. Their radiological features suggest malignant neoplasms, whereas they are not. Consequently, this is an underdiagnosed entity and only after an histological exam could a definitive diagnosis be achieved. TEACHING POINTS: • Their radiological features suggest malignant neoplasms, whereas they are not • CT and MR imaging are the most used tools in their evaluation • IMT is an underdiagnosed entity • The definitive diagnosis is only after histological exam
format Online
Article
Text
id pubmed-4330239
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-43302392015-02-19 Inflammatory myofibroblastic tumours: a pictorial review Cantera, Jon Etxano Alfaro, María Páramo Rafart, David Cano Zalazar, Romina Muruzabal, Maite Millor Barquín, Paula García Pérez, Isabel Vivas Insights Imaging Pictorial Review OBJECTIVES: To present the most important characteristics of inflammatory myofibroblastic tumours (IMTs) arising in different locations of the body with histological correlation. METHODS: To review the symptoms and main radiological findings of IMTs. On ultrasonography (US), these tumours can appear as hypoechoic or hyperechoic masses and a variable Doppler appearance with increased vascularity. Computed tomography (CT) and magnetic resonance (MR) are the most used imaging tools in their evaluation. On contrast-enhanced CT, IMTs can appear as homogeneous or heterogeneous lesions, with variable enhancement on delayed acquisitions due to fibrosis. These findings are also present on gadolinium contrast-enhanced MR. On T1-weighted and T2-weighted sequences, IMTs usually show low signal intensity reflecting also the presence of fibrotic tissue. RESULTS: To show the main clinical symptoms and radiological features of IMTs in different locations: head and neck, lung, genitourinary, hepatic, splenic, gastrointestinal tract, mesenteric, muskuloskeletal. CONCLUSIONS: Although IMTs in some organs are not uncommon, they are not usually included in the differential diagnosis of masses. Their radiological features suggest malignant neoplasms, whereas they are not. Consequently, this is an underdiagnosed entity and only after an histological exam could a definitive diagnosis be achieved. TEACHING POINTS: • Their radiological features suggest malignant neoplasms, whereas they are not • CT and MR imaging are the most used tools in their evaluation • IMT is an underdiagnosed entity • The definitive diagnosis is only after histological exam Springer Berlin Heidelberg 2014-12-18 /pmc/articles/PMC4330239/ /pubmed/25519466 http://dx.doi.org/10.1007/s13244-014-0370-0 Text en © The Author(s) 2014 https://creativecommons.org/licenses/by/4.0/ Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Pictorial Review
Cantera, Jon Etxano
Alfaro, María Páramo
Rafart, David Cano
Zalazar, Romina
Muruzabal, Maite Millor
Barquín, Paula García
Pérez, Isabel Vivas
Inflammatory myofibroblastic tumours: a pictorial review
title Inflammatory myofibroblastic tumours: a pictorial review
title_full Inflammatory myofibroblastic tumours: a pictorial review
title_fullStr Inflammatory myofibroblastic tumours: a pictorial review
title_full_unstemmed Inflammatory myofibroblastic tumours: a pictorial review
title_short Inflammatory myofibroblastic tumours: a pictorial review
title_sort inflammatory myofibroblastic tumours: a pictorial review
topic Pictorial Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4330239/
https://www.ncbi.nlm.nih.gov/pubmed/25519466
http://dx.doi.org/10.1007/s13244-014-0370-0
work_keys_str_mv AT canterajonetxano inflammatorymyofibroblastictumoursapictorialreview
AT alfaromariaparamo inflammatorymyofibroblastictumoursapictorialreview
AT rafartdavidcano inflammatorymyofibroblastictumoursapictorialreview
AT zalazarromina inflammatorymyofibroblastictumoursapictorialreview
AT muruzabalmaitemillor inflammatorymyofibroblastictumoursapictorialreview
AT barquinpaulagarcia inflammatorymyofibroblastictumoursapictorialreview
AT perezisabelvivas inflammatorymyofibroblastictumoursapictorialreview